Compass Therapeutics, Inc.·4

Dec 10, 2:02 PM ET

Shin Barry 4

4 · Compass Therapeutics, Inc. · Filed Dec 10, 2024

Insider Transaction Report

Form 4
Period: 2024-12-09
Transactions
  • Award

    Common Stock

    2024-12-09$1.65/sh+400,000$660,000400,000 total
  • Award

    Stock Option (Right to Buy)

    2024-12-09+400,000400,000 total
    Exercise: $1.65Exp: 2034-12-09Common Stock (400,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSU") granted to the reporting person on December 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vesting on December 9, 2025.
  • [F2]The options vest as follows: 25% on December 9, 2025, with the remaining over 36 substantially equal monthly installments starting January 9, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary